Early detection and diagnosis of prostate cancer may be achieved using the prostate-specific antigen (PSA) test; however, the PSA test suffers from low specificity and a high false-positive rate, which may lead to overtreatment of indolent prostate cancers. The gene discussed is KLK3; the disease is prostate carcinoma.